Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

Ademi LLP is investigating Bio-Techne (NASDAQ: TECH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

Thursday, July 2, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Applied ...

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for s ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

The Pharma Letter’s June M&A coverage showed that biopharma buyers remain prepared to pay heavily for late-stage or strategically useful assets, while also using smaller deals to fill technology and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Is LQDA a good stock to buy? We came across a bullish thesis on Liquidia Corporation on r/GrowthStockInvesting by symbaeu. In ...

In a collaborative analysis of lipid-lowering therapy trials, high-sensitivity C-reactive protein (hsCRP) was a stronger predictor ...

Eli Lilly, Regeneron, and five other companies have been selected to take part in the FDA's PreCheck pilot programme, designed to make it easier and quicker to set up US manufacturing facilities. The ...

In today’s newsletter: Lisa Hannum , Nicki Gibbs , Ayme Zemke and Rebecca Martin on successful succession planning, Vance Brown at Boston Scientific on three traits of young professionals, Adam Grant ...